Latest Period
Q1 2026
Security Snapshot
First Trust Exchange-Traded Fund - First Trust NYSE(R) Arca(R) Biotechnology Index Fund (FBT) Institutional Ownership
CUSIP: 33733E203
13F Institutional Holders and Ownership History from Q1 2014 to Q2 2026
Institutions Reporting
307
Shares (Excl. Options)
8,238,854
Price
$200.82
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / First Trust NYSE(R) Arca(R) Biotechnology Index Fund
- Symbol
- FBT
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 8,238,854
- Total 13F value
- $1,654,811,915
- Portfolio coverage rank
- 0%
- Share change
- +4,789,998
- Value change
- +$961,563,456
- Number of holders
- 307
- Shares outstanding
- 11,350,962
- SEC-reported price per share
- $247.54
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
2 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- FBT - First Trust Exchange-Traded Fund - First Trust NYSE(R) Arca(R) Biotechnology Index Fund is tracked under CUSIP 33733E203.
- 307 institutions reported positions in Q1 2026.
- 1 significant owner is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 307 to 146 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $1,654,811,915 to $210,764,763.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 307 institutions filings for Q1 2026.
Security key
33733E203
Latest holder period
Q1 2026
13F holders
307
13D/G owners
1
CIK / CUSIP context first
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 33733E203:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
1
Security
FBT
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| FIRST TRUST PORTFOLIOS LP | 30% | -7.4% | $842,167,356 | -$62,932,578 | 3,397,343 | -7% | First Trust Portfolios L.P. | 30 Jun 2026 |
As of 31 Mar 2026, 307 institutional investors reported holding 8,238,854 shares of First Trust Exchange-Traded Fund - First Trust NYSE(R) Arca(R) Biotechnology Index Fund (FBT). This represents 73% of the company’s total 11,350,962 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
60%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| FIRST TRUST ADVISORS LP | 31% | 3,515,093 | +49661% | 0.5% | $705,899,999 |
| MORGAN STANLEY | 4.7% | 534,200 | +33% | 0.01% | $107,278,181 |
| WELLS FARGO & COMPANY/MN | 3.8% | 426,213 | +126% | 0.02% | $85,592,121 |
| LPL Financial LLC | 2.6% | 295,687 | +13% | 0.02% | $59,379,791 |
| UBS Group AG | 1.8% | 205,366 | +9.8% | 0.01% | $41,241,600 |
| RAYMOND JAMES FINANCIAL INC | 1.8% | 202,877 | +39% | 0.01% | $40,741,826 |
| BANK OF AMERICA CORP /DE/ | 1.8% | 200,959 | +5.7% | 0% | $40,356,665 |
| ROYAL BANK OF CANADA | 1.8% | 199,981 | +29% | 0.01% | $40,160,000 |
| ENVESTNET ASSET MANAGEMENT INC | 1.1% | 126,996 | +11% | 0.01% | $25,503,363 |
| Berger Financial Group, Inc | 0.92% | 104,402 | -9.2% | 1.2% | $20,966,008 |
| Nilsine Partners, LLC | 0.84% | 95,083 | +1715% | 1.5% | $19,388,375 |
| &PARTNERS | 0.69% | 78,413 | +1119% | 0.08% | $15,746,887 |
| 360 Financial, Inc. | 0.69% | 78,213 | +8.5% | 4.7% | $15,706,735 |
| Advisory Services Network, LLC | 0.66% | 75,428 | 0.2% | $15,147,500 | |
| WCG Wealth Advisors LLC | 0.65% | 74,342 | 0.42% | $14,929,286 | |
| AMERIPRISE FINANCIAL INC | 0.61% | 69,393 | +52% | 0% | $13,927,558 |
| STIFEL FINANCIAL CORP | 0.61% | 68,981 | +14% | 0.01% | $13,853,094 |
| Cetera Investment Advisers | 0.58% | 66,297 | +5.5% | 0.01% | $13,313,679 |
| Janney Montgomery Scott LLC | 0.57% | 65,265 | -6.8% | 0.03% | $13,107,000 |
| NewEdge Advisors, LLC | 0.55% | 62,524 | +961% | 0.05% | $12,555,986 |
| BENJAMIN EDWARDS INC | 0.51% | 58,201 | +91% | 0.12% | $11,694,711 |
| ASSETMARK, INC | 0.49% | 55,217 | +19% | 0.02% | $11,088,678 |
| TRUIST FINANCIAL CORP | 0.48% | 54,147 | -2% | 0.01% | $10,873,894 |
| D.A. DAVIDSON & CO. | 0.47% | 53,019 | +6.5% | 0.06% | $10,647,378 |
| OSAIC HOLDINGS, INC. | 0.46% | 52,725 | -0.31% | 0.02% | $10,590,647 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
50
Latest
Q1 2026
Rows shown
1-25 of 50
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 850,300 | $210,764,763 | -$9,724,684 | $247.89 | 146 |
| 2026 Q1 | 8,238,854 | $1,654,811,915 | +$961,563,456 | $200.82 | 307 |
| 2025 Q4 | 3,444,827 | $711,622,833 | +$83,120,046 | $206.52 | 278 |
| 2025 Q3 | 3,042,011 | $545,834,448 | -$11,896,976 | $179.29 | 252 |
| 2025 Q2 | 3,155,408 | $509,245,856 | -$41,077,763 | $161.33 | 247 |
| 2025 Q1 | 3,418,328 | $576,824,224 | +$1,866,805 | $170.12 | 266 |
| 2024 Q4 | 3,418,857 | $568,580,158 | +$41,645,148 | $166.21 | 253 |
| 2024 Q3 | 3,143,605 | $540,228,542 | -$50,274,497 | $171.93 | 252 |
| 2024 Q2 | 3,468,418 | $534,289,452 | +$6,575,921 | $153.99 | 247 |
| 2024 Q1 | 3,399,038 | $522,621,545 | -$94,532,990 | $153.77 | 240 |
| 2023 Q4 | 4,017,594 | $634,837,157 | -$30,986,867 | $158.06 | 254 |
| 2023 Q3 | 4,190,296 | $613,262,596 | -$62,820,801 | $146.35 | 239 |
| 2023 Q2 | 4,617,487 | $707,129,055 | -$19,966,454 | $153.14 | 247 |
| 2023 Q1 | 4,700,385 | $728,635,260 | -$18,428,171 | $155.03 | 241 |
| 2022 Q4 | 4,877,768 | $751,529,554 | +$55,433,739 | $154.13 | 239 |
| 2022 Q3 | 4,496,690 | $593,813,874 | +$22,209,350 | $131.98 | 212 |
| 2022 Q2 | 4,332,609 | $587,753,929 | -$18,206,139 | $135.56 | 218 |
| 2022 Q1 | 4,448,675 | $663,407,924 | -$82,106,064 | $149.14 | 212 |
| 2021 Q4 | 4,955,742 | $802,113,791 | -$46,741,875 | $161.96 | 239 |
| 2021 Q3 | 5,178,909 | $859,978,174 | -$14,178,042 | $166.06 | 230 |
| 2021 Q2 | 5,220,166 | $900,985,426 | -$80,585,265 | $172.62 | 227 |
| 2021 Q1 | 5,725,862 | $919,195,735 | -$21,822,779 | $160.50 | 232 |
| 2020 Q4 | 5,809,688 | $976,622,166 | -$78,183,499 | $167.99 | 232 |
| 2020 Q3 | 6,096,208 | $959,021,765 | -$32,144,151 | $157.26 | 210 |
| 2020 Q2 | 6,226,658 | $1,045,067,619 | +$191,623,157 | $167.77 | 222 |